Image created by Dr. Michael J. Miller
Neogen Corporation announced the launch of the new Neogen Molecular Detection Assay 2 – Salmonella Enteritidis/Salmonella Typhimurium (MDA2SEST).
The product joins several other next-generation assays, including Salmonella, E. coli O157 (including H7), Listeria and Listeria monocytogenes, Campylobacter, STEC gene screen (stx and eae) and Cronobacter, as part of the Neogen Molecular Detection System pathogen testing platform.
"We are pleased to bring this advanced technology to our customers, helping them to enhance their food safety program and address a challenging need in the poultry industry," said John Adent, Neogen's president and CEO. "This isothermal molecular assay overcomes certain limitations of existing solutions, such as traditional serology and PCR-based methods, with improved accuracy, reduced time to results and a streamlined workflow that provides increased productivity and unparalleled ease of use."
The Neogen MDA2SEST kit is used with the Neogen Molecular Detection System for rapid and specific detection of two Salmonella serotypes, Salmonella enterica subsp. enterica serotype Enteritidis (SE) and Salmonella enterica subsp. enterica serotype Typhimurium (including monophasic variant 1,4,[5],12:i:-) (ST), in enriched poultry samples. Salmonella Enteritidis and Salmonella Typhimurium are two serotypes that are pathogenic to humans and have been implicated in Salmonella outbreaks. By enabling the detection of specific serotypes such as S. Enteritidis and S. Typhimurium, the MDA2SEST assay can help reduce foodborne illness.
The Neogen MDA2SEST was granted approval by the AOAC Research Institute Performance Tested Methods (PTM) Program and assigned PTM Certification No. 122302. The PTM Program provides independent third-party review and certification for proprietary test method performance.
The Neogen Molecular Detection System platform is used by food processors, universities, governments and contract testing laboratories in more than 40 countries. It is powered by a combination of advanced technologies — isothermal DNA amplification and bioluminescence detection. The new assay for Salmonella Enteritidis and Salmonella Typhimurium joins, and can be run concurrently with, molecular tests already offered by Neogen for Salmonella, E. coli O157 (including H7), Listeria and Listeria monocytogenes, Campylobacter, STEC gene screen (stx and eae), and Cronobacter.